[
  {
    "ts": null,
    "headline": "Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need",
    "summary": "Don't follow general market sentiment when it comes to these two stocks.",
    "url": "https://finnhub.io/api/news?id=eaa8321343ff9942d4d291922adb45e022896096229a7fff6223f41244aa820f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772385780,
      "headline": "Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need",
      "id": 139271142,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Don't follow general market sentiment when it comes to these two stocks.",
      "url": "https://finnhub.io/api/news?id=eaa8321343ff9942d4d291922adb45e022896096229a7fff6223f41244aa820f"
    }
  },
  {
    "ts": null,
    "headline": "Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?",
    "summary": "Eli Lilly is making headlines in the pharmaceutical sector, but it's a very expensive stock.",
    "url": "https://finnhub.io/api/news?id=26f1e12f32cfae6d12be49adb78ca7e3c1c9b5ce227628443efadac20d5c2588",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772363100,
      "headline": "Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?",
      "id": 139269486,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Eli Lilly is making headlines in the pharmaceutical sector, but it's a very expensive stock.",
      "url": "https://finnhub.io/api/news?id=26f1e12f32cfae6d12be49adb78ca7e3c1c9b5ce227628443efadac20d5c2588"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy right now. Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. announced on February 27 positive results from the Phase 3 EV-304 clinical trial for PADCEVTM, a Nectin-4 directed antibody-drug conjugate, in combination with Keytruda®, a PD-1 inhibitor, in patients with muscle-invasive bladder […]",
    "url": "https://finnhub.io/api/news?id=d5e8b0e97dbaaa733240563dfe8edb2eade413e0c9a5bb851d51c7f62210b631",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772357274,
      "headline": "Pfizer Inc. (PFE) and Astellas Pharma Announce Positive Results From the Phase 3 EV-304 Clinical Trial for PADCEVTM",
      "id": 139268978,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Inc. (NYSE:PFE) is one of the best cheap stocks under $50 to buy right now. Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. announced on February 27 positive results from the Phase 3 EV-304 clinical trial for PADCEVTM, a Nectin-4 directed antibody-drug conjugate, in combination with Keytruda®, a PD-1 inhibitor, in patients with muscle-invasive bladder […]",
      "url": "https://finnhub.io/api/news?id=d5e8b0e97dbaaa733240563dfe8edb2eade413e0c9a5bb851d51c7f62210b631"
    }
  },
  {
    "ts": null,
    "headline": "14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)",
    "summary": "Discover Marchâs GASV large-cap value screen: 14 fair-priced âsaferâ dividend stocks, projected gains to 2027, and cash-flow risk flagsâread now.",
    "url": "https://finnhub.io/api/news?id=8f6656c4c5a77ead9888cdce24e552a4ff10128ee4b3fd6cf94b99b18a08f481",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772352606,
      "headline": "14 Ideal 'Safer' Dividend Buys From 29 Of 69 March Graham Value All-Stars (GVAS)",
      "id": 139269784,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1302662749/image_1302662749.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover Marchâs GASV large-cap value screen: 14 fair-priced âsaferâ dividend stocks, projected gains to 2027, and cash-flow risk flagsâread now.",
      "url": "https://finnhub.io/api/news?id=8f6656c4c5a77ead9888cdce24e552a4ff10128ee4b3fd6cf94b99b18a08f481"
    }
  }
]